SimuSkinâ„¢ is the result of Simulab's persistent efforts in research and development. SimuSkinâ„¢ has been meticulously designed to emulate human tissue with accuracy in appearance, feel, tactile, and ...
SEATTLE, WA / ACCESSWIRE / July 23, 2024 / Simulab Corporation, a leading healthcare simulation manufacturing company headquartered in Seattle, Washington, is pleased to announce the launch of its ...
Continuing to evolve with the standard of practice for your training. SEATTLE, WASHINGTON / ACCESS Newswire / February 24, 2026 / Simulab Corporation, a leader in soft-tissue simulation for over 30 ...
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Surgical Simulation Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The surgical simulation market is ...
SEATTLE, WA / ACCESSWIRE / January 18, 2024 / Simulab Corporation, a leader in the medical simulation industry headquartered in Seattle, WA, proudly unveils its latest technology - SimuSkin. This ...